Why do women benefit more from Omega-3s at every stage of their lives?

Scientific research delivers a clear message: women need Omega-3s more than men and utilize them more effectively. While benefits for fetal development are well-known, they represent just part of the picture. Women across all life stages benefit from adequate EPA and DHA intake - the marine-derived Omega-3s.

When recommending Omega-3 food sources, fatty fish like sardines and anchovies naturally come to mind - rich in EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), the directly utilizable forms that modulate inflammatory processes.

Though not technically "essential" nutrients (humans can synthesize them), EPA and DHA are considered functionally essential. Studies on adult males estimate poor conversion rates from their precursor (alpha-linolenic acid/ALA from walnuts/flaxseeds): just 8% for EPA and 0-4% for DHA. But research focusing on women reveals different results.

Women Produce More EPA/DHA Than Men

In 2002, University of Southampton researchers Graham Burdge and Stephen Wootton shifted focus to women in their British Journal of Nutrition study. Their premise was pragmatic: fetuses needing preformed EPA/DHA for proper development depend entirely on maternal supply, creating significant nutritional demands. "We needed to understand," they explained, "whether non-pregnant young women differ from men in long-chain Omega-3 polyunsaturated fatty acid metabolism, particularly ALA-to-EPA/DHA conversion."

By administering labeled ALA to six women (24-32 years) and tracking labeled fats in their blood for 21 days, researchers estimated a 21% ALA-to-EPA conversion rate - markedly higher than male studies showed. DHA conversion also proved greater in women at 9%. "Comparison with previous studies," they concluded, "suggests women have greater ALA conversion capacity than men."

This finding gained support from subsequent research. A 2014 Nutrition Journal meta-analysis by Caroline Childs' team at Southampton confirmed that increased ALA intake raises membrane phospholipid EPA levels more significantly in women than men.

Omega-3 Benefits in Pregnancy and Lactation

Burdge and Wootton's fetal-focused premise suggests women's enhanced EPA/DHA production evolved to meet pregnancy demands. Scientific literature supports this: based on evidence for fetal/infant development, EFSA authorizes health claims that maternal DHA "contributes to normal brain and eye development of fetus and breastfed infants."

However, current data indicate these polyunsaturated fats benefit mothers too. As noted in Biomedicine & Pharmacotherapy by INSERM's Jean-Marie Bourre, "High EPA/DHA intake slightly prolongs gestation and improves its quality" - likely through anti-inflammatory actions and improved placental blood flow.

Research suggests Omega-3 roles in preventing preeclampsia and managing gestational diabetes (associated with reduced placental Omega-3 transfer). Bourre also highlights that "Omega-3 fatty acids (...) probably reduce postpartum depression risk" - linked to inadequate Omega-3 intake, rapid depletion during pregnancy/lactation, limited fish consumption, low breastmilk DHA, and inflammation.

Omega-3 Benefits in Reproductive Years and Menopause

Beyond maternity, adequate Omega-3 intake promotes women's health throughout life. During reproductive years, studies suggest benefits for dysmenorrhea, PMS, PCOS and infertility - mediated by anti-inflammatory effects, insulin sensitivity improvement, lipid/hormonal profile modulation, and enhanced uterine perfusion/oocyte quality.

During/perimenopause, Omega-3s may counter typical cardiovascular risk increases and other health challenges. Evidence indicates potential against vasomotor symptoms, depression, and osteoporosis. More broadly, literature supports roles in combating age-related cognitive decline, osteoarthritis, and certain cancers (particularly breast/colon).

Regarding breast cancer specifically, a 2023 Food Science & Nutrition review by Shirin Osouli-Tabrizi et al noted "significant reductions in perceived stress, sleep disturbances, depression, pain, joint stiffness and fatigue" among Omega-3 users. They concluded these fatty acids "may induce physical, mental, and certain inflammatory/metabolic parameter improvements during or after breast cancer treatment."

The Mechanisms

Enhanced ALA-to-DHA conversion in oral contraceptive users suggests estrogen boosts activity of conversion enzymes (desaturases/elongases). This hypothesis draws support from older human/animal studies and recent work by Korean researcher Donghee Kim in British Journal of Nutrition.

Kim's rat experiments demonstrated estrogen injection increases transcription of genes encoding these enzymes. Combined with low linoleic acid diets (reducing Omega-6 competition for enzymes), estrogen raised hepatic DHA levels.

Estrogen's regulatory role may also contribute to physiological maternal blood DHA increases during pregnancy.

Omega-3 Recommendations for Women

Italian Society of Human Nutrition (SINU) recommends all women consume 250mg combined EPA+DHA daily, plus 100-200mg DHA during pregnancy/lactation. EFSA additionally emphasizes 200mg extra daily DHA for fetal/infant brain/eye development. Dosage clarity diminishes for other potential applications.

Gram-range doses may be needed in some cases. Current specific recommendations primarily address cardiovascular, brain and eye benefits:

- 250mg/day EPA+DHA for normal heart, brain and eye function
- 2g/day EPA+DHA for triglyceride control
- 3g/day EPA+DHA for blood pressure management

References:

Abodi M, De Cosmi V, Parazzini F, Agostoni C. Omega-3 fatty acids dietary intake for oocyte quality in women undergoing assisted reproductive techniques: A systematic review. Eur J Obstet Gynecol Reprod Biol. 2022 Aug;275:97-105. doi: 10.1016/j.ejogrb.2022.06.019

Bourre JM. Dietary omega-3 fatty acids for women. Biomed Pharmacother. 2007 Feb-Apr;61(2-3):105-12. doi: 10.1016/j.biopha.2006.09.015

Burdge GC, Wootton SA. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr. 2002 Oct;88(4):411-20. doi: 10.1079/BJN2002689

Childs CE, Kew S, Finnegan YE, Minihane AM, Leigh-Firbank EC, Williams CM, Calder PC. Increased dietary α-linolenic acid has sex-specific effects upon eicosapentaenoic acid status in humans: re-examination of data from a randomised, placebo-controlled, parallel study. Nutr J. 2014 Dec 11;13(1):113. doi: 10.1186/1475-2891-13-113

Commissione Europea. Food and Feed Information Portal Database. Last accessed: 03/25/25

Firouzabadi FD, Shab-Bidar S, Jayedi A. The effects of omega-3 polyunsaturated fatty acids supplementation in pregnancy, lactation, and infancy: An umbrella review of meta-analyses of randomized trials. Pharmacol Res. 2022 Mar;177:106100. doi: 10.1016/j.phrs.2022.106100

Kim D, Choi JE, Park Y. Low-linoleic acid diet and oestrogen enhance the conversion of α-linolenic acid into DHA through modification of conversion enzymes and transcription factors. Br J Nutr. 2019 Jan;121(2):137-145. doi: 10.1017/S0007114518003252

Mohammadi MM, Dehghan Nayeri N, Mashhadi M, Varaei S. Effect of omega-3 fatty acids on premenstrual syndrome: A systematic review and meta-analysis. J Obstet Gynaecol Res. 2022 Jun;48(6):1293-1305. doi: 10.1111/jog.15217

Osouli-Tabrizi S, Mehdizadeh A, Naghdi M, Sanaat Z, Vahed N, Farshbaf-Khalili A. The effectiveness of omega-3 fatty acids on health outcomes in women with breast cancer: A systematic review. Food Sci Nutr. 2023 May 22;11(8):4355-4371. doi: 10.1002/fsn3.3409

Saldeen P, Saldeen T. Women and omega-3 Fatty acids. Obstet Gynecol Surv. 2004 Oct;59(10):722-30; quiz 745-6. doi: 10.1097/01.ogx.0000140038.70473.96

Società Italiana di Nutrizione Umana-SINU, 2014. LARN - Reference intake levels for Italian population: LIPIDS.

Snipe RMJ, Brelis B, Kappas C, Young JK, Eishold L, Chui JM, Vatvani MD, Nigro GMD, Hamilton DL, Convit L, Carr A, Condo D. Omega-3 long chain polyunsaturated fatty acids as a potential treatment for reducing dysmenorrhoea pain: Systematic literature review and meta-analysis. Nutr Diet. 2024 Feb;81(1):94-106. doi: 10.1111/1747-0080.12835

Wang J, Gaman MA, Albadawi NI, Salem A, Kord-Varkaneh H, Okunade KS, Alomar O, Al-Badawi IA, Abu-Zaid A. Does Omega-3 Fatty Acid Supplementation Have Favorable Effects on the Lipid Profile in Postmenopausal Women? A Systematic Review and Dose-response Meta-analysis of Randomized Controlled Trials. Clin Ther. 2023 Jan;45(1):e74-e87. doi: 10.1016/j.clinthera.2022.12.009

Zhang MM, Zou Y, Li SM, Wang L, Sun YH, Shi L, Lu L, Bao YP, Li SX. The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials. Transl Psychiatry. 2020 Jun 17;10(1):193. doi: 10.1038/s41398-020-00886-3